(Q40605843)

English

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

scientific article published on February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Epstein–Barr virus

0 references

Catherine M Bollard

2

object named as

Catherine M Bollard

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cliona M Rooney

9

object named as

Cliona M Rooney

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Malcolm Brenner

7

object named as

Malcolm K Brenner

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

8

object named as

Helen E Heslop

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

4

object named as

M Helen Huls

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Hans-Joachim Wagner

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Stéphane Vigouroux

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Robert Anderson

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

H Grant Prentice

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

81-91

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Principles for adoptive T cell therapy of human viral diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Immunotherapy against antigenic tumors: a game with a lot of players

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Dendritic cell vaccination for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Functions of CD8 T-cell subsets secreting different cytokine patterns.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Th1 and Th2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Interleukin 12: a new clinical player in cytokine therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Interleukin-12 in anti-tumor immunity and immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Episomal vectors rapidly and stably produce high-titer recombinant retrovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

21 January 2018

TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

7 January 2021

based on heuristic

inferred from DOI database lookup

Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700664

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700664

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40605843&oldid=2203823035"